Search results for: Pricing and Reimbursement
Filter search results
The Expanding Value Footprint of Oncology Treatments
13 May 2014
…may not be evident at the time of first approval and value can vary both over time and by indication. This may result in pricing and reimbursement decisions that fail…
CBO Doesn’t Capture The Real Impact of H.R. 3 on Innovation
14 September 2021
…scientific understanding that is contributing to increasing rate of NMEs and smaller population sizes, as we discussed previously. In some disease areas, like neurology and metabolic disorders, genomics and other…
OHE Annual Lecture 2023 | The ECO-nomics of Health in a Shifting Climate: Fostering Well-being, Sustainable Livelihoods, and a Greener Future
13 September 2023, 6:00pm
…change emissions, protect the environment and improve the livelihoods of resource-dependent communities. She works on climate change and systemic risk; and tracking the co-benefits of climate change mitigation and health,…
Pricing in Emerging Markets: Income, Competition and Procurement
16 August 2011
…is far less in doubt, allowing competition on price, not brand and (2) the procurement process attracts multinational generic suppliers that have scale and other cost and quality advantages relative…
Pricing Variations Within and Across Countries: Gauging Efficiency
25 February 2014
This research explores which approaches to pricing can produce the greatest efficiency and access to medicines within and across countries. OHE collaborated on two articles published in the journal Health…
What are the Economic Implications of Moving Away from Paying a Single Price for a Single Drug?
9 July 2018
…The term indication-based pricing (IBP) is often used in medical and health economics literature to refer to this concept. In an OHE Consulting report published last month, Towse, Cole and…
The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries
5 January 2018
…indications? Indication-based pricing (IBP) has been proposed as a way to tackle this issue, permitting price to vary according to indication and – critically – according to value. The notion…
Indication-Based Pricing (IBP) Discussion Paper: Should drug prices differ by indication?
1 May 2019
Increasingly, scientific advances are delivering new medicines that deliver improved survival and quality of life across multiple treatment indications. Indication-Based Pricing (IBP) has been proposed as a way to better…
Indication-Based Pricing (IBP) Consultation Report
1 April 2020
…those medicines becomes critical in making sure we can benefit from them. “Indication-based pricing” (IBP) permits price to vary according to indication and has been proposed to tackle this issue….